Arbutus Biopharma Corp (ABUS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -63,745 | -153,723 | -57,060 | -84,413 | -384,164 |
| Depreciation Amortization | 1,978 | 68,335 | 16,992 | 42,825 | 392,439 |
| Income taxes - deferred | N/A | -12,661 | -4,282 | -24,320 | -105,061 |
| Accounts receivable | -108 | 227 | -1,029 | -129 | 735 |
| Other Working Capital | 431 | -2,225 | -4,275 | 3,147 | -467 |
| Other Operating Activity | 10,003 | 29,041 | -18,212 | 14,250 | 38,633 |
| Operating Cash Flow | $-51,441 | $-71,006 | $-67,866 | $-48,640 | $-57,885 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -12,180 | 28,916 | 118,566 | 35,086 | -82,551 |
| PPE Investments | -229 | -578 | -1,113 | -7,261 | -3,971 |
| Net Acquisitions | -2,500 | N/A | N/A | N/A | N/A |
| Purchase Of Investment | N/A | N/A | -121,580 | N/A | -12,601 |
| Investing Cash Flow | $-14,909 | $28,338 | $-4,127 | $27,825 | $-99,123 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 86,746 | 18,908 | 1,382 | 453 | 637 |
| Other Financing Activity | 0 | 18,549 | 54,264 | 48,869 | 12,001 |
| Financing Cash Flow | $86,746 | $37,457 | $55,646 | $49,322 | $12,638 |
| Exchange Rate Effect | 56 | 68 | -1,003 | 2,372 | 1,004 |
| Beginning Cash Position | 31,799 | 36,942 | 54,292 | 23,413 | 166,779 |
| End Cash Position | 52,251 | 31,799 | 36,942 | 54,292 | 23,413 |
| Net Cash Flow | $20,452 | $-5,143 | $-17,350 | $30,879 | $-143,366 |
| Free Cash Flow | |||||
| Operating Cash Flow | -51,441 | -71,006 | -67,866 | -48,640 | -57,885 |
| Capital Expenditure | -229 | -589 | -1,138 | -7,264 | -3,996 |
| Free Cash Flow | -51,670 | -71,595 | -69,004 | -55,904 | -61,881 |